Another study in Nature Medicine in 2024 further discovered that HBOT upregulates miR-210-3p to suppress HIF-1α translation, thereby inhibiting tumor angiogenesis and enhancing sensitivity to radiotherapy (43). This evidence concerns the gene HIF1A and neoplasm.